Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Sotagliflozin in patients with diabetes and recent worsening heart failure
Deepak L. Bhatt
, Michael Szarek
, P. Gabriel Steg
, Christopher P. Cannon
, Lawrence A. Leiter
, Darren K. McGuire
, Julia B. Lewis
, Matthew C. Riddle
, Adriaan A. Voors
, Marco Metra
, Lars H. Lund
, Michel Komajda
, Jeffrey M. Testani
, Christopher S. Wilcox
, Piotr Ponikowski
, Renato D. Lopes
, Subodh Verma
, Pablo Lapuerta
, Bertram Pitt
Research output
:
Contribution to journal
›
Article
›
peer-review
1525
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Sotagliflozin in patients with diabetes and recent worsening heart failure'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Patients with Diabetes
100%
Worsening Heart Failure
100%
Sotagliflozin
100%
Placebo Groups
50%
Placebo
33%
Hazard Ratio
25%
Confidence Interval
25%
Hospitalization
16%
Heart Failure
16%
Number of Deaths
16%
Death Rate
16%
First Dose
16%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
16%
Type 2 Diabetes Mellitus (T2DM)
8%
Acute Kidney Injury
8%
Number of Events
8%
Acute Decompensated Heart Failure
8%
Hypotension
8%
Diarrhea
8%
Double-blind Trial
8%
Heart Failure Hospitalization
8%
Sanofi
8%
Type 2 Diabetic Patients
8%
Lexicon
8%
Subsequent Events
8%
Hospitalization Risk
8%
Severe Hypoglycemia
8%
Stable Heart Failure
8%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Sotagliflozin
100%
Placebo
83%
sodium glucose cotransporter-2 inhibitors
16%
Hypotension
8%
Acute Kidney Failure
8%
Heart Death
8%
Hypoglycemia
8%
Diarrhea
8%
Maturity Onset Diabetes of the Young
8%